Skip to Main Content

The developer of the wildly popular Lumosity “brain training” games has agreed to pay $2 million in refunds to settle federal charges that it deceived customers about the cognitive and health benefits of its apps and online products.

The agreement, announced Tuesday by the Federal Trade Commission, marks the highest profile — and most costly — crackdown so far on a burgeoning industry that’s increasingly come under fire from scientists and regulators in recent months.


Regulators accused San Francisco-based Lumos Labs of making unfounded claims about what its games could do to delay the symptoms of and protect against conditions like dementia and Alzheimer’s disease, and to reduce cognitive impairment from stroke and attention deficit hyperactivity disorder.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.